Skip to Main content Skip to Navigation
Journal articles

Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

Abstract : Controlled studies and most observational studies published over the last 5 years suggest that the addition of synthetic progestins to estrogen in hormone replacement therapy (HRT), particularly in continuous-combined regimen, increases the breast cancer (BC) risk compared to estrogen alone. By contrast, a recent study suggests that the addition of natural progesterone in cyclic regimens does not affect BC risk. This finding is consistent with in vivo data suggesting that progesterone does not have a detrimental effect on breast tissue. The increased BC risk found with the addition of synthetic progestins to estrogen could be due to the regimen and/or the kind of progestin used. Continuous-combined regimen inhibits the sloughing of mammary epithelium that occurs after progesterone withdrawal in a cyclic regimen. More importantly, the progestins used (medroxyprogesterone acetate and 19-Nortestosterone-derivatives) are endowed with some non-progesterone-like effects, which can potentiate the proliferative action of estrogens. Particularly relevant seem to be the metabolic and hepatocellular effects (decreased insulin sensitivity, increased levels and activity of insulin-like growth factor-I, and decreased levels of SHBG), which contrast the opposite effects induced by oral estrogen.
Complete list of metadatas

Cited literature [132 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00151947
Contributor : F. Clavel-Chapelon <>
Submitted on : Tuesday, June 5, 2007 - 5:36:57 PM
Last modification on : Wednesday, October 14, 2020 - 3:59:31 AM
Long-term archiving on: : Thursday, April 8, 2010 - 5:29:37 PM

Identifiers

Citation

Carlo Campagnoli, Françoise Clavel-Chapelon, Rudolf Kaaks, Clementina Peris, Franco Berrino. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.. Journal of Steroid Biochemistry and Molecular Biology, Elsevier, 2005, 96 (2), pp.95-108. ⟨10.1016/j.jsbmb.2005.02.014⟩. ⟨inserm-00151947⟩

Share

Metrics

Record views

508

Files downloads

1648